InCrowd Survey: NASH-Treating Physician Perspectives

See the more-recent, 2019 NASH Report

InCrowd conducted 30-minute MicroQual interviews with four physicians considered key opinion leaders on Non-alcoholic Steatohepatitis (NASH). Then used this feedback to develop a 5-minute quantitative MicroSurvey for 55 gastroentologists and hepatologists.

Research Objectives:

  • Determine physician interests in and perspectives on NASH treatments in development.

  • Gauge the prevalence of comorbid conditions that require physician management alongside NASH and understand which physician specialties are ultimately stakeholders in patient care.

Method: 5-minute MicroSurvey via InCrowd
Crowds: US Gastroenterologists, Hepatologists
Sample Size: n=55
Fielding Period: April 25-26, 2018

One key insight: physicians feel that any effective treatment for NASH will need to be a combination regimen, versus a single agent, that helps resolve liver fibrosis, reduce liver inflammation, and interrupt the storage of fat in the liver.

Download the full report now!

Please fill out the form below to access this content

This field is for validation purposes and should be left unchanged.

Related Resources

Why Diversity Matters to Patients

Why Diversity Matters to Patients

How does a diverse patient audience feel about representation among their own physicians? Is the diversity outlook improving among healthcare professionals? Find out in our latest report from the 2023 Pharma Market Research Conference. We examined: Satisfaction with...

read more
ASH 2022 Real-Time Round-Up

ASH 2022 Real-Time Round-Up

The 2022 Annual Meeting of the American Society of Hematology (ASH) took place in person from December 10th to the 13th. InCrowd wanted to learn from those Hematologists and Hematology-Oncologists who attended these two objectives: Explore which condition had the most...

read more